2-cyclopropyl-6-hydroxy-3,4-dihydropyrimidin-4-one, 95+%, 250mg

tert-Butyl ((1-(hydroxymethyl)cyclopentyl)methyl)carbamate, 97%, 1g

Ethyl 3-(2-hydroxyphenyl)propanoate, 97%, 1g

2,4-Dibromo-6-fluorobenzamide, 97%, 1g

Tetrabutylammonium Bis(3,4,6-trichloro-1,2-benzenedithiolato)nickelate>95.0%(T)200mg

4-(2,2-Diethoxyethyl)morpholine, 95.0%, 10g

3-(3-fluorophenyl)-2'-trifluoromethylpropiophenone, 97.0%, 1g

5-fluoro-2-(4-morpholinyl)-4-pyrimidinamine, 95.0%, 1g

1-(1-Methylcyclohexyl)methanamine, 95.0%, 25g

Monoammonium Glycyrrhizinate>75.0%(HPLC)1g

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(prop-2-yn-1-yl)pentanamide, 95+%, 100mg

tert-Butyl 4-bromo-2-hydroxybenzoate, 95.0%, 250mg

Methyl 2-bromopyrimidine-5-carboxylate, 95+%, 100mg